C197H211F2N31O27S — CID 158694953
methyl N-[(1R)-2-[(2S,4S)-4-(difluoromethoxymethyl)-2-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-1H-benzo[e]indol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate;methyl N-[(1R)-2-[(2S,4S)-2-[7-[2-[(1R,3S,5R)-2-[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(2S,4S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-4-methylsulfanylpyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(1R)-2-[(2S,4S)-2-[7-[2-[(1R,3S,5R)-2-[(2S,3S)-2-(methoxycarbonylamino)-3-methylpentanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (PubChem CID 158694953) has the molecular formula C197H211F2N31O27S and a molecular weight of 3515.11 g/mol. Its IUPAC name is methyl N-[(1R)-2-[(2S,4S)-4-(difluoromethoxymethyl)-2-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-1H-benzo[e]indol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate;methyl N-[(1R)-2-[(2S,4S)-2-[7-[2-[(1R,3S,5R)-2-[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(2S,4S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-4-methylsulfanylpyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(1R)-2-[(2S,4S)-2-[7-[2-[(1R,3S,5R)-2-[(2S,3S)-2-(methoxycarbonylamino)-3-methylpentanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate.
| Compound Name | methyl N-[(1R)-2-[(2S,4S)-4-(difluoromethoxymethyl)-2-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-1H-benzo[e]indol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate;methyl N-[(1R)-2-[(2S,4S)-2-[7-[2-[(1R,3S,5R)-2-[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(2S,4S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-4-methylsulfanylpyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(1R)-2-[(2S,4S)-2-[7-[2-[(1R,3S,5R)-2-[(2S,3S)-2-(methoxycarbonylamino)-3-methylpentanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate |
|---|---|
| PubChem CID | 158694953 |
| Molecular Formula | C197H211F2N31O27S |
| Molecular Weight | 3515.11 g/mol |
| Exact Mass | 3512.58 |
| IUPAC Name | methyl N-[(1R)-2-[(2S,4S)-4-(difluoromethoxymethyl)-2-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-1H-benzo[e]indol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate;methyl N-[(1R)-2-[(2S,4S)-2-[7-[2-[(1R,3S,5R)-2-[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(2S,4S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-4-methylsulfanylpyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(1R)-2-[(2S,4S)-2-[7-[2-[(1R,3S,5R)-2-[(2S,3S)-2-(methoxycarbonylamino)-3-methylpentanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate |
| SMILES | CC[C@H](C)[C@H](NC(=O)OC)C(=O)N1[C@@H]2C[C@@H]2C[C@H]1c1nc2c(ccc3cc(-c4ccc5c(ccc6[nH]c([C@@H]7C[C@H](COC)CN7C(=O)[C@H](NC(=O)OC)c7ccccc7)nc65)c4)ccc32)[nH]1.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(ccc3cc(-c4ccc5c(ccc6[nH]c([C@@H]7C[C@H](SC)CN7C(=O)[C@@H](NC(=O)OC)C(C)C)nc65)c4)ccc32)[nH]1)C(C)C.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(ccc3cc(-c4ccc5c6c(ccc5c4)N=C([C@@H]4C[C@H](COC(F)F)CN4C(=O)[C@H](NC(=O)OC)c4ccccc4)C6)ccc32)[nH]1)C(C)C.COC[C@H]1C[C@@H](c2nc3c(ccc4cc(-c5ccc6c(ccc7[nH]c([C@@H]8C[C@H]9C[C@H]9N8C(=O)[C@@H](NC(=O)OC)C(C)(C)C)nc76)c5)ccc43)[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1 |
| InChI | InChI=1S/2C51H54N8O7.C50H51F2N7O7.C45H52N8O6S/c1-51(2,3)44(57-50(63)66-6)48(61)59-38-23-33(38)24-40(59)46-53-37-19-15-32-22-30(13-17-35(32)43(37)55-46)29-12-16-34-31(21-29)14-18-36-42(34)54-45(52-36)39-20-27(26-64-4)25-58(39)47(60)41(56-49(62)65-5)28-10-8-7-9-11-28;1-6-27(2)42(56-50(62)65-4)49(61)59-39-23-34(39)24-41(59)47-53-38-19-15-33-22-31(13-17-36(33)45(38)55-47)30-12-16-35-32(21-30)14-18-37-44(35)54-46(52-37)40-20-28(26-64-3)25-58(40)48(60)43(57-51(63)66-5)29-10-8-7-9-11-29;1-27(2)42(56-49(62)64-3)46(60)58-20-8-11-40(58)45-54-38-19-15-33-23-31(13-17-35(33)44(38)55-45)30-12-16-34-32(22-30)14-18-37-36(34)24-39(53-37)41-21-28(26-66-48(51)52)25-59(41)47(61)43(57-50(63)65-4)29-9-6-5-7-10-29;1-23(2)36(50-44(56)58-5)42(54)52-18-8-9-34(52)40-46-32-16-12-27-19-25(10-14-30(27)38(32)48-40)26-11-15-31-28(20-26)13-17-33-39(31)49-41(47-33)35-21-29(60-7)22-53(35)43(55)37(24(3)4)51-45(57)59-6/h7-19,21-22,27,33,38-41,44H,20,23-26H2,1-6H3,(H,52,54)(H,53,55)(H,56,62)(H,57,63);7-19,21-22,27-28,34,39-43H,6,20,23-26H2,1-5H3,(H,52,54)(H,53,55)(H,56,62)(H,57,63);5-7,9-10,12-19,22-23,27-28,40-43,48H,8,11,20-21,24-26H2,1-4H3,(H,54,55)(H,56,62)(H,57,63);10-17,19-20,23-24,29,34-37H,8-9,18,21-22H2,1-7H3,(H,46,48)(H,47,49)(H,50,56)(H,51,57)/t27-,33+,38+,39-,40-,41+,44+;27-,28-,34+,39+,40-,41-,42-,43+;28-,40-,41-,42-,43+;29-,34-,35-,36-,37-/m0000/s1 |
| InChIKey | IGUYNHUNGDKMCG-XYIQRUTFSA-N |
| XLogP | 33.56 |
| TPSA | 709.93 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 44 |
| Heavy Atoms | 258 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3515.11 |
| LogP ≤ 5 | 33.56 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 36 |